Wave Life Sciences Ltd. (WVE)

Chimerix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	208.48	302.08	200.35	88.5	150.56	184.5
Cash & Short-Term Investments	208.48	302.08	200.35	88.5	150.56	184.5
Cash Growth	35.41%	50.77%	126.39%	-41.22%	-18.39%	25.37%
Accounts Receivable	1.62	1.42	21.09	-	-	30
Receivables	1.62	1.42	21.09	-	-	30
Prepaid Expenses	6.7	9.54	9.91	7.93	6.58	10.43
Other Current Assets	6.76	7.35	4.02	2.11	5.42	5.11
Total Current Assets	223.56	320.39	235.37	98.54	162.56	230.04
Property, Plant & Equipment	24.29	28	35.72	44.13	40.64	45.43
Other Long-Term Assets	4.51	3.82	3.86	3.72	3.8	3.77
Total Assets	252.36	352.21	274.95	146.39	207.01	279.24
Accounts Payable	14.66	16.26	12.84	16.92	7.28	13.8
Accrued Expenses	13.03	21.08	16.83	17.55	14.86	11.97
Current Portion of Leases	8.14	7.64	6.71	5.5	4.96	3.71
Current Unearned Revenue	51.58	65.97	150.06	31.56	37.1	91.56
Total Current Liabilities	87.41	110.95	186.44	71.52	64.2	121.04
Long-Term Leases	13.58	17.77	25.4	32.12	24.96	25.59
Long-Term Unearned Revenue	4.23	6.1	15.6	79.77	77.48	41.48
Other Long-Term Liabilities	-	-	-	0.19	-	0.47
Total Liabilities	105.22	134.82	227.45	183.6	166.64	188.59
Common Stock	1,191	1,175	935.37	802.83	749.85	694.09
Additional Paid-In Capital	167.6	156.45	129.24	119.44	87.98	71.57
Retained Earnings	-1,219	-1,122	-1,025	-967.34	-805.51	-683.27
Comprehensive Income & Other	-0.16	-0.26	-0.12	-0.03	0.18	0.39
Total Common Equity	139.27	209.52	39.63	-45.09	32.5	82.78
Shareholders' Equity	147.14	217.39	47.5	-37.22	40.37	90.65
Total Liabilities & Equity	252.36	352.21	274.95	146.39	207.01	279.24
Total Debt	21.71	25.4	32.12	37.61	29.92	29.31
Net Cash (Debt)	186.77	276.67	168.23	50.88	120.65	155.19
Net Cash Growth	49.32%	64.46%	230.63%	-57.83%	-22.26%	35.40%
Net Cash Per Share	1.20	2.00	1.59	0.65	2.33	3.96
Filing Date Shares Outstanding	155.67	153.49	122.28	98.1	60.84	49
Total Common Shares Outstanding	155.67	153.04	119.16	86.92	59.84	48.78
Working Capital	136.15	209.44	48.93	27.02	98.36	109
Book Value Per Share	0.89	1.37	0.33	-0.52	0.54	1.70
Tangible Book Value	139.27	209.52	39.63	-45.09	32.5	82.78
Tangible Book Value Per Share	0.89	1.37	0.33	-0.52	0.54	1.70
Machinery	-	26.19	26.07	25.51	25.66	25.42
Construction In Progress	-	0.35	0.29	0.32	0.03	0.08
Leasehold Improvements	-	28.89	28.53	28.41	27.99	27.91

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q